At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Robotic-assisted peripheral vascular interventiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CorPath® 200 RAPID II Study (Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease)
In Brief
A clinical study evaluating Robotic-assisted peripheral vascular intervention for Peripheral Arterial Disease. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and performance of the CorPath 200 System in the remote delivery and manipulation of guidewires and rapid exchange catheters for use in percutaneous vascular interventions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesAustria
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedApr 2016
Primary CompletionMay 2016
Study CompletionAug 2016
TodayJul 2026
First PostedApr 18, 2016
Enrollment StartMar 1, 2016
Primary CompletionMay 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.2 years ago
Interventions
Robotic-assisted peripheral vascular interventiondevice
Remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventions.